Table 4.
DTC survivors | Childhood cancer survivors (CCS) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Total CCS | P value | Leukemia/lymphoma | P value | Solid tumors | P value | Brain tumors | P value | ||
n | 35 | 76 | 45 | 23 | 8 | ||||
Social development† | 22 (21, 23) | 21 (19, 22) | 0.005 | 20 (18, 22) | 0.001 | 22 (19, 23) | 0.164 | 21.5 (20.3, 22.8) | 0.391 |
Autonomy development‡ | 9 (8, 10) | 9 (8, 10) | 0.688 | 10 (8, 10) | 0.753 | 9 (8, 10.5) | 0.677 | 9 (7.5, 11) | 0.890 |
Psychosexual development§ | 8 (7, 8) | 7 (6, 8) | 0.020 | 7 (6, 8) | 0.040 | 7 (6, 8) | 0.083 | 5.5 (4.3, 8) | 0.097 |
Scores are shown as median (p25, p27). Comparisons between DTC survivors and other groups were performed using Mann–Whitney U tests. Higher scores indicate earlier achievement or achievement of more psychosocial developmental milestones; †scale ranges 12–24; ‡scale ranges 6–12; §scale ranges 4–8. Missing values were excluded from statistical testing (pairwise deletion). P values in bold indicate a significant value (P < 0.01).
CCS, childhood cancer survivors; DTC, differentiated thyroid carcinoma.